Navigation Links
Immunetics Wins $2.8 Million Contract for New Type of HIV Test
Date:5/18/2010

Boston-based Immunetics won a $2.8 million contract from the National Institutes of Health to develop a new test for HIV that will prevent a false positive diagnosis in individuals who have received HIV vaccines in clinical trials. The vaccine response alone results in a false positive result with current HIV tests, resulting in erroneous diagnosis.

Boston, Mass (PRWEB) May 18, 2010 -- Immunetics, Inc. (Boston, MA) has been selected to receive a $2.8 million contract as part of the National Heart, Lung, and Blood Institute’s (NHLBI) Retrovirus Epidemiology Donor Study-II (REDS-II) project, a long term epidemiologic study of blood safety involving HIV and other infectious and non-infectious complications of blood transfusion.

The contract will be administered by Westat, a research organization based in Rockville, MD, which is the coordinating center for the REDS-II project. Under the contract, Immunetics will develop and supply a new test for HIV, which will uniquely distinguish individuals infected with HIV from those who have been immunized with experimental HIV vaccines in clinical trials. At present, vaccination leads to a false positive result on the current generation of HIV screening tests, a problem highlighted by recent publications in medical journals.

Clinical trials for HIV vaccines have involved thousands of vaccine recipients worldwide and continue to enroll more subjects, who stand to benefit from availability of the new test. The NHLBI initiated this project because it will provide a test which will be useful in screening blood donors in those regions of the world where HIV vaccine trials have been or are being conducted and to avoid the permanent deferral of those donors found not to be infected with HIV. Immunetics will work with a consortium of researchers at the National Institutes of Health, the Food and Drug Administration’s Center for Biologics Evaluation and Research where the original research leading to the new test was carried out, Blood Systems Research Institute in San Francisco, and others. The contract is valued at $9.2 million with all options exercised.

“This contract award presents a major opportunity for Immunetics and will leverage our longtime experience in the field of HIV diagnostics and assay development” said Dr. Andrew Levin, Immunetics' CEO and Scientific Director who will be the Principal Investigator on the project. “We see a great fit between our technology and the basic scientific advances made by the research teams at CBER and NIH. Given the vital need for an effective HIV vaccine, the test which we will be developing could play an essential role in current and future vaccine trials. We are particularly pleased to announce this award today, which has been designated by the NIH as National HIV Vaccine Awareness Day, and are very excited by the potential to make a significant contribution to public health in this area.”

Immunetics offers state-of-the-art assay technology for infectious disease diagnosis and pathogen detection, and for over ten years has been a leading innovator of tests for bacterial, viral and parasitic diseases. The company produces and markets a range of infectious disease assay kits and instruments. Its mission is better, cost-efficient care through more accurate diagnosis.

Contact: Andrew Levin - 617-896-9100 ext. 13 or alevin(at)immunetics(dot)com

# # #

Read the full story at http://www.prweb.com/releases/2010/05/prweb4015214.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Safe & Secure Online Pharmacy Viamedic.com; Reaches Milestone of 1.5 Million Orders Processed
2. More Than 1 Million Invitations Anticipated for National ‘Back To Church Sunday,' Set for Sept. 12
3. Millions Are Losing Their Hearing Unnecessarily; Noise-Induced Hearing Loss Is Always Preventable, Says HearUSA Audiologist
4. Infectious diseases caused two-thirds of the nearly 9 million child deaths globally in 2008
5. Enter One Year Auction Contest; You Could Win 5% of Winning Bid or Buy Now - $1 Million Option Proceeds
6. $18.5 Million New Jersey Medical Malpractice Birth Injury Verdict Due To Cerebral Palsy Caused By A Delayed C-Section
7. $1.9 million grant to help UCF find multiple sclerosis nerve-ana
8. NIH awards $2.7-million grant to Kent State to study cognitive impairment in heart failure patients
9. MU awarded $8.5 million to explore tiny vessels role in cardiovascular diseases
10. Hutchinson Center receives $10.24 million from NIH for Latina breast cancer research
11. NIH awards $10 million to Rush University Medical Center to address health disparities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... Hills, California (PRWEB) , ... February 17, 2017 ... ... info@drvallecillos.com , drvallecillos.com , Beverly Hills plastic surgeon Dr. ... subcutaneous fat cells. , Dr. Vallecillos says, "Traditionally, plastic surgery has been centered ...
(Date:2/18/2017)... , ... February 18, 2017 , ... ... provides the latest information and contact points to easily connect elderly veterans of ... assisted living, and elder-care funding. It also conveys material on this year's increase ...
(Date:2/17/2017)... ... February 17, 2017 , ... The Alliance ... change designed to further positively impact the health and wellness of our community ... considered it our duty to seriously consider releasing our assets beyond our 5% ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... **An FDAnews Webinar**, Feb. 22, 2017 — 1:30 p.m. – 2:30 p.m. ... manufacturers should be asking before selecting an FDA approval pathway? , How ...
(Date:2/17/2017)... WA (PRWEB) , ... February 17, 2017 , ... ... management organizations, has been named a finalist in the 8th Annual DecisionHealth Platinum ... America's healthcare delivery system. Qualis Health’s work is recognized across multiple award categories, ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... Feb. 17, 2017  BioDigital, Inc., creators of ... of their 3D body mapping technology with eClinicalWorks, ... new integration will be used to capture and ... of the human body. BioDigital pilots show using ... while also increasing the precision of clinical annotations ...
(Date:2/16/2017)... -- Absorption Systems, a global leader in nonclinical testing ... announce that its Chief Operating Officer, Sid Bhoopathy ... the 2017 Executive Management Award. The award is sponsored ... for their creative management vision, leadership philosophy, innovative strategy ... is on March 8, 2017 at the Ballroom at ...
(Date:2/16/2017)... 2017 DaVita Inc. (NYSE: DVA ) ... 31, 2016. Net income attributable to DaVita ... was $158 million, or $0.80 per share and $880 million, ... income attributable to DaVita Inc. for the quarter and year ... was $192 million, or $0.98 per share, and $789 million, ...
Breaking Medicine Technology: